financetom
Business
financetom
/
Business
/
NexGold COO Jeremy Wyeth Steps Down
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NexGold COO Jeremy Wyeth Steps Down
Aug 28, 2025 4:19 AM

07:10 AM EDT, 08/28/2025 (MT Newswires) -- NeXGold Mining ( NXGCF ) , which rose 12% to 52-week highs Wednesday, overnight said Jeremy Wyeth has stepped down from the position of chief operating officer due to the restructuring of its executive management team.

Rachel Pineault has also stepped down as executive vice president, governance and corporate affairs of NexGold.

Shares of the company closed up $0.110 at $1.010 on Wednesday on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rheinmetall in talks with OHB about German army satellite project, says source
Rheinmetall in talks with OHB about German army satellite project, says source
Mar 11, 2026
DUESSELDORF, Germany, Jan 26 (Reuters) - Rheinmetall is in talks with ‌satellite maker OHB about ​a satellite project for the German ‍armed forces, a ⁠person ⁠familiar with the talks told Reuters on ‌Monday, boosting ​OHB's stock. Germany's OHB confirmed in a statement ⁠only that ‍it ​was in discussions with Rheinmetall on joint bids for unspecified ‍state orders. OHB confirms ongoing...
Century takes 40% stake in EGA's US aluminium smelter
Century takes 40% stake in EGA's US aluminium smelter
Mar 11, 2026
* EGA and Century to jointly own venture in 60:40 split * Capacity of smelter in Oklahoma raised to 750,000 tons * Production seen starting before end of the ‌decade (Adds detail, background) Jan 26 (Reuters) - Century Aluminum ( CENX ) will take a 40% ​stake in Emirates Global Aluminium's project to build ‍the first primary aluminium smelter in...
Sarepta Therapeutics Says Duchenne Muscular Dystrophy Patients Show Benefits 3 Years After Treatment
Sarepta Therapeutics Says Duchenne Muscular Dystrophy Patients Show Benefits 3 Years After Treatment
Mar 11, 2026
09:07 AM EST, 01/26/2026 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) said Monday that three-year results from part 1 of a phase 3 EMBARK study of its gene therapy, Elevidys, in ambulatory patients with Duchenne muscular dystrophy showed continued benefit. The company said patients who received the therapy showed statistically significant efficacy on key motor function tests three years...
Cogent Biosciences Says Bezuclastinib for Gastrointestinal Stromal Tumors Gets FDA's Breakthrough Therapy Designation
Cogent Biosciences Says Bezuclastinib for Gastrointestinal Stromal Tumors Gets FDA's Breakthrough Therapy Designation
Mar 11, 2026
09:08 AM EST, 01/26/2026 (MT Newswires) -- Cogent Biosciences ( COGT ) said Monday that the US Food and Drug Administration has granted breakthrough therapy designation for bezuclastinib in combination with sunitinib for patients with Gastrointestinal Stromal Tumors or GIST. The designation is based on the company's Peak trial that demonstrated a substantial and highly statistically significant clinical benefit on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved